BioCentury
ARTICLE | Clinical News

Ixmyelocel-T: Phase IIb ongoing

April 14, 2014 7:00 AM UTC

Aastrom said an independent DSMB recommended continuation of the double-blind, placebo-controlled, U.S. Phase IIb ixCELL-DCM trial of ixmyelocel-T based on a planned interim review of unblinded safety...